These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 17938328

  • 1. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
    Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P.
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
    [Abstract] [Full Text] [Related]

  • 2. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW, Chuang TC, Yang AH, Hsu CK, Kao MC.
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [Abstract] [Full Text] [Related]

  • 4. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C, von Struensee D, Bierer S, Bögemann M, Hertle L, Eltze E.
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [Abstract] [Full Text] [Related]

  • 5. Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.
    Santin AD, Bellone S, Van Stedum S, Bushen W, De Las Casas LE, Korourian S, Tian E, Roman JJ, Burnett A, Pecorelli S.
    Gynecol Oncol; 2005 Jul; 98(1):24-30. PubMed ID: 15894362
    [Abstract] [Full Text] [Related]

  • 6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [Abstract] [Full Text] [Related]

  • 7. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.
    Tsiambas E, Karameris A, Dervenis C, Lazaris AC, Giannakou N, Gerontopoulos K, Patsouris E.
    JOP; 2006 May 09; 7(3):283-94. PubMed ID: 16685109
    [Abstract] [Full Text] [Related]

  • 8. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
    Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG.
    Cancer Res; 1994 Nov 01; 54(21):5675-82. PubMed ID: 7522962
    [Abstract] [Full Text] [Related]

  • 9. HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy.
    Junker K, Stachetzki U, Rademacher D, Linder A, Macha HN, Heinecke A, Müller KM, Thomas M.
    Lung Cancer; 2005 Apr 01; 48(1):59-67. PubMed ID: 15777971
    [Abstract] [Full Text] [Related]

  • 10. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
    Kazakov DV, Ivan D, Kutzner H, Spagnolo DV, Grossmann P, Vanecek T, Sima R, Kacerovska D, Shelekhova KV, Denisjuk N, Hillen U, Kuroda N, Mukensnabl P, Danis D, Michal M.
    Am J Dermatopathol; 2009 May 01; 31(3):236-47. PubMed ID: 19384064
    [Abstract] [Full Text] [Related]

  • 11. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD, Bellone S, Van Stedum S, Bushen W, Palmieri M, Siegel ER, De Las Casas LE, Roman JJ, Burnett A, Pecorelli S.
    Cancer; 2005 Oct 01; 104(7):1391-7. PubMed ID: 16116605
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R, Naeem R, Marconi S, Luszcz J, Garb J, Gasparini R, Otis CN.
    Hum Pathol; 2001 Dec 01; 32(12):1344-50. PubMed ID: 11774167
    [Abstract] [Full Text] [Related]

  • 13. HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique.
    Langner C, Gross C, Rehak P, Ratschek M, Rüschoff J, Zigeuner R.
    Urology; 2005 Jan 01; 65(1):176-80. PubMed ID: 15667899
    [Abstract] [Full Text] [Related]

  • 14. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.
    Pellegrini C, Falleni M, Marchetti A, Cassani B, Miozzo M, Buttitta F, Roncalli M, Coggi G, Bosari S.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3645-52. PubMed ID: 14506153
    [Abstract] [Full Text] [Related]

  • 15. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R, Lara PN, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R.
    Cancer; 2002 Sep 01; 95(5):1009-15. PubMed ID: 12209684
    [Abstract] [Full Text] [Related]

  • 16. Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.
    Cuadros M, Talavera P, López FJ, García-Peréz I, Blanco A, Concha A.
    Pathobiology; 2010 Sep 01; 77(1):38-45. PubMed ID: 20185966
    [Abstract] [Full Text] [Related]

  • 17. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 18. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
    Kammori M, Kurabayashi R, Kashio M, Sakamoto A, Yoshimoto M, Amano S, Kaminishi M, Yamada T, Takubo K.
    Oncol Rep; 2008 Mar 01; 19(3):651-6. PubMed ID: 18288397
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG.
    Clin Cancer Res; 2002 Feb 01; 8(2):540-8. PubMed ID: 11839675
    [Abstract] [Full Text] [Related]

  • 20. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
    Giltnane JM, Murren JR, Rimm DL, King BL.
    Histopathology; 2006 Aug 01; 49(2):161-9. PubMed ID: 16879393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.